| Issuer | % of Class | Filed |
|---|---|---|
|
CollPlant Biotechnologies Ltd.
13G
CLGN · M2R51X124
|
5.7% |
10/8/2026
Event 9/30/2026
|
|
CollPlant Biotechnologies Ltd.
13D/A
Amendment 5
CLGN · M2R51X124
|
5.7% |
10/8/2026
Event 9/30/2026
|
|
Collplant Biotechnologies Ltd.
13D/A
Amendment 4
CLGN · 19516R107
|
12.9% |
11/28/2025
Event 11/19/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.